Page images
PDF
EPUB

Division of Reproductive and Developmental

Toxicology.

Division of Genetic Toxicology.

Division of Biochemical Toxicology. Division of Nutritional Toxicology.

Division of Biometry and Risk Assessment.

Division of Chemistry.

Division of Microbiology.

Division of Neurotoxicology.

Office of Research Support

Veterinary Services Staff.

Information Technology Staff.

Division of Administrative Services. Division of Facilities Engineering and Maintenance.

OFFICE OF REGULATORY AFFAIRS. 3

Office of the Associate Commissioner Contaminants Policy Coordination Staff. Equal Employment Opportunity Staff. Strategic Initiatives Staff.

Office of Resource Management

Division of Planning, Evaluation, and Management.

Division of Information Systems.

Division of Human Resource Development.
Division of Management Operations.

Office of Enforcement

Medical Products Quality Assurance Staff. Division of Compliance Management and Operations.

Division of Compliance Policy.

Office of Regional Operations

Division of Federal-State Relations.
Division of Field Science.

Division of Emergency and Investigational
Operations.

Division of Import Operations and Policy.

Office of Criminal Investigations1

Northeast Regional Office. 5
Mid-Atlantic Regional Office.

Southeast Regional Office."
Midwest Regional Office. 8
Southwest Regional Office. 9

3 Mailing address: 5600 Fishers Lane, Rockville, MD 20857.

4 Mailing address: 7500 Standish Pl., rm. 250N, Rockville, MD 20855.

5 Mailing address: 850 Third Ave., Brooklyn, NY 11232.

6 Mailing address: 900 U. S. Customhouse, Second and Chestnut Sts., rm. 900, Philadelphia, PA 19106.

'Mailing address: 60 Eighth St. NE., Atlanta, GA 30309.

Mailing address: 20 North Michigan Ave., Chicago, IL 60606.

Mailing address: 7920 Elmbrook Dr., Dallas, TX 75247.

[blocks in formation]
[blocks in formation]
[blocks in formation]

Division of Microbiological Studies.

Office of Systems and Support

Quality Assurance Staff.

Office of Constituent Operations

Consumer Education Staff.
Legislative Activities Staff.

Industry Activities Staff.

International Activities Staff.

Office of Field Programs

Division of Enforcement.

Division of HACCP Programs.
Division of Cooperative Programs.
Division of Field Program Planning and
Evaluation.

Office of Management Systems

Safety Management Staff.

Division of Information Resources Management.

Division of Planning and Resources Management.

Office of Scientific Analysis and Support

Division of Mathematics.

Division of General Scientific Support.
Division of Market Studies.

CENTER FOR VETERINARY MEDICINE. 22

Office of the Center Director

Office of Management and Communications Administrative Staff. Communications Staff.

Program Planning and Evaluation Staff. Information Resources Management Staff.

Office of Surveillance and Compliance

Division of Compliance.
Division of Animal Feeds.

Division of Epidemiology and Surveillance.

Office of New Animal Drug Evaluation Division of Biometrics and Production Drugs.

Division of Manufacturing Technologies. Division of Therapeutic Drugs for Food Animals.

Division of Therapeutic Drugs for Non-Food Animals.

Division of Human Food Safety.

Office of Research

Administrative Staff.

Division of Residue Chemistry.

Division of Animal Research.

[62 FR 13822, Mar. 24, 1997]

22 Mailing address: 7500 Standish Pl., MPN2, Rockville MD 20855.

§ 5.205 Chief Counsel, Food and Drug Administration.

The Chief Counsel to the Commissioner of Food and Drugs is the Associate General Counsel, Food and Drug Division, Office of the General Counsel, Department of Health and Human Services, Room 6-57, 5600 Fishers Lane, Rockville, MD 20857.

[46 FR 8455, Jan. 27, 1981, as amended at 56 FR 8709, Mar. 1, 1991. Redesignated at 62 FR 13824, Mar. 24, 1997]

§5.210 FDA Public Information Offices.

(a) Dockets Management Branch (HFA305). The Dockets Management Branch Public Room is located in rm. 1-23, 12420 Parklawn Dr., Rockville, MD 20857. Telephone: 301-443-1753.

(b) Freedom of Information Staff (HFI35). The Freedom of Information Public Room is located in rm. 12A-30, Parklawn Bldg., 5600 Fishers Lane, Rockville, MD 20857. Telephone: 301-443-6310.

(c) Press Relations Staff (HFI-40). The Press Offices are located in rm. 15-05, Parklawn Bldg., 5600 Fisher Lane, Rockville, MD 20857. Telephone: 301443-3285; and in rm. 3807, FB-8, 200 C St. SW., Washington, DC 20204. Telephone 202-205-4144.

[62 FR 13824, Mar. 24, 1997]

§ 5.215 Field structure.

NORTHEAST REGION

Regional Field Office: 850 Third Ave., Brooklyn, NY 11232.

Northeast Regional Laboratory: 850 Third Ave., Brooklyn, NY 11232-1593.

New York District Office: 850 Third Ave., Brooklyn, NY 11232-1593.

New England District Office: One Montvale Ave., Stoneham, MA 02180.

Buffalo District Office: 599 Delaware Ave., Buffalo, NY 14202.

MID-ATLANTIC REGION

Regional Field Office: 900 U.S. Customhouse, Second and Chestnut Sts., rm. 900, Philadelphia, PA 19106.

Philadelphia District Office: 900 U.S. Customhouse, Second and Chestnut Sts., rm. 900, Philadelphia, PA 19106.

Baltimore District Office: 900 Madison Ave., Baltimore, MD 21201-2199.

Cincinnati District Office: 1141 Central Pkwy., Cincinnati, OH 45202-1097.

[blocks in formation]
[blocks in formation]

Subpart D [Reserved]

Subpart E-Criminal Violations

7.84 Opportunity for presentation of views before report of criminal violation. 7.85 Conduct of a presentation of views before report of criminal violation. 7.87 Records related to opportunities for

presentation of views conducted before report of criminal violation.

AUTHORITY: Secs. 201-903 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321393); secs. 301, 351, 354-360F, 361 of the Public Health Service Act (42 U.S.C. 241, 262, 263b263n, 264).

SOURCE: 42 FR 15567, Mar. 22, 1977, unless otherwise noted.

Subpart A-General Provisions §7.1 Scope.

This part governs the practices and procedures applicable to regulatory enforcement actions initiated by the Food and Drug Administration pursuant to the Federal Food, Drug and Cosmetic Act (21 U.S.C. 301 et seq.) and other laws that it administers. This part also provides guidelines for manufacturers and distributors to follow with respect to their voluntary removal or correction of marketed violative products. This part is promulgated to clarify and explain the regulatory practices and procedures of the Food and Drug Administration, enhance public understanding, improve consumer protection, and assure uniform and consistent application of practices and procedures throughout the agency.

[43 FR 26218, June 16, 1978]

« PreviousContinue »